BioXcel Therapeutics, Inc. (BTAI) Operating income 2017–2025
BioXcel Therapeutics, Inc. (BTAI) annual operating income history from SEC filings — each fiscal year as reported.
-$50.5MFY2025 · since FY2017: -$4.5M → -$50.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.5M | +25.0% |
| FY2024 | -$67.2M | +60.9% |
| FY2023 | -$171.8M | -7.6% |
| FY2022 | -$159.6M | -49.3% |
| FY2021 | -$106.9M | -29.9% |
| FY2020 | -$82.3M | -144.9% |
| FY2019 | -$33.6M | -68.3% |
| FY2018 | -$20.0M | -340.0% |
| FY2017 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice